1. Home
  2. FLUX vs PULM Comparison

FLUX vs PULM Comparison

Compare FLUX & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLUX
  • PULM
  • Stock Information
  • Founded
  • FLUX N/A
  • PULM 2003
  • Country
  • FLUX United States
  • PULM United States
  • Employees
  • FLUX N/A
  • PULM N/A
  • Industry
  • FLUX Industrial Machinery/Components
  • PULM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLUX Miscellaneous
  • PULM Health Care
  • Exchange
  • FLUX Nasdaq
  • PULM Nasdaq
  • Market Cap
  • FLUX 25.4M
  • PULM 20.5M
  • IPO Year
  • FLUX N/A
  • PULM N/A
  • Fundamental
  • Price
  • FLUX $1.79
  • PULM $5.48
  • Analyst Decision
  • FLUX Strong Buy
  • PULM
  • Analyst Count
  • FLUX 2
  • PULM 0
  • Target Price
  • FLUX $6.00
  • PULM N/A
  • AVG Volume (30 Days)
  • FLUX 151.9K
  • PULM 11.7K
  • Earning Date
  • FLUX 08-15-2025
  • PULM 08-12-2025
  • Dividend Yield
  • FLUX N/A
  • PULM N/A
  • EPS Growth
  • FLUX N/A
  • PULM N/A
  • EPS
  • FLUX N/A
  • PULM N/A
  • Revenue
  • FLUX $63,074,000.00
  • PULM $1,921,000.00
  • Revenue This Year
  • FLUX $11.10
  • PULM N/A
  • Revenue Next Year
  • FLUX $12.66
  • PULM $134.88
  • P/E Ratio
  • FLUX N/A
  • PULM N/A
  • Revenue Growth
  • FLUX N/A
  • PULM N/A
  • 52 Week Low
  • FLUX $1.15
  • PULM $1.78
  • 52 Week High
  • FLUX $3.99
  • PULM $10.40
  • Technical
  • Relative Strength Index (RSI)
  • FLUX 48.92
  • PULM 28.72
  • Support Level
  • FLUX $1.70
  • PULM $5.60
  • Resistance Level
  • FLUX $2.15
  • PULM $6.15
  • Average True Range (ATR)
  • FLUX 0.19
  • PULM 0.29
  • MACD
  • FLUX -0.04
  • PULM -0.08
  • Stochastic Oscillator
  • FLUX 26.80
  • PULM 4.29

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: